YSYusuke Sakaguchi

Yusuke Sakaguchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yusuke Sakaguchi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Tatsuya Shoji

    Department of Kidney Disease and Hypertension, Osaka General Medical Center, 3-1-56 Bandaihigashi Sumiyoshi-ku, Osaka, 558-8558, Japan

    6 shared publications
  • Yoshiharu Tsubakihara

    Committee of Renal Data Registry Japanese Society for Dialysis Therapy Tokyo Japan

    5 shared publications
  • Akira Suzuki

    §Clinical Laboratory, Osaka General Medical Center, Osaka, Japan

    4 shared publications
  • Hiromi Rakugi

    Department of Geriatric and General Medicine The University of Osaka Graduate School of Medicine Suita Japan

    4 shared publications
  • Terumasa Hayashi

    Department of Kidney Disease and Hypertension, Osaka General Medical Center, 3-1-56 Bandaihigashi Sumiyoshi-ku, Osaka, 558-8558, Japan

    4 shared publications
  • Hiroaki Kawabata

    Department of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan

    3 shared publications

Latest Publications

  • Open Access

    TO028PROTEINURIA AND DIABETES MELLITUS AS RISK FACTORS OF HYPOMAGNESEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE

    by Tatsufumi Oka, Takayuki Hamano, Masamitsu Senda, Sayoko Yonemoto, Yusuke Sakaguchi, Chikako Nakano, Yoshitaka Isaka

    Introduction and Aims: Hypomagnesemia is an independent predictor for faster progression of chronic kidney disease (CKD) with or without diabetes mellitus (DM), as we reported previously (KI. 2015, Diabetes Care. 2012). However, the causes of hypomagnesemia in this population are still uncertain. The purpose of this study was to identify independent risk factors for hypomagnesemia.

  • Open Access

    Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study

    by Yusuke Sakaguchi, Naohiko Fujii, Tatsuya Shoji, Terumasa Hayashi, Hiromi Rakugi, Kunitoshi Iseki, Yoshiharu Tsubakihara, Yoshitaka Isaka, the Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy

    In vitro studies have shown inhibitory effects of magnesium (Mg) on phosphate-induced calcification of vascular smooth muscle cells, raising the possibility that maintaining a high Mg level may be useful for reducing cardiovascular risks of patients with hyperphosphatemia. We examined how serum Mg levels affect the association between serum phosphate levels and the risk of cardiovascular mortality in patients undergoing hemodialysis. A nationwide register-based cohort study was conducted using database of the Renal Data Registry of the Japanese Society for Dialysis Therapy in 2009. We identified 142,069 patients receiving in-center hemodialysis whose baseline serum Mg and phosphate levels were available. Study outcomes were one-year cardiovascular and all-cause mortality. Serum Mg levels were categorized into three groups (lower, P = 0.03). Serum Mg levels significantly modified the mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis.


  • Association of Nocturnal Hypoxemia with Progression of CKD

    by Yusuke Sakaguchi, Tsuguru Hatta, Terumasa Hayashi, Tatsuya Shoji, Akira Suzuki, Kodo Tomida, Noriyuki Okada, Hiromi Rakugi, Yoshitaka Isaka, Yoshiharu Tsubakihara

    Summary: Background and objectives: Nocturnal hypoxemia is highly prevalent among patients with CKD. Nocturnal hypoxemia contributes to systemic inflammation, oxidative stress, endothelial cell dysfunction, and activation of the renin-angiotensin system, which are common pathologic mechanisms of CKD progression. This study investigated whether nocturnal hypoxemia is independently associated with CKD progression. Design, setting, participants, & measurements: This two-center retrospective cohort study included 161 patients with stages 3–4 CKD enrolled from January of 2009 to July of 2011 with a body mass index less than 25.0 kg/m2. The 4% oxygen desaturation index, the number of events per hour in which oxygen saturation decreases by >4% during sleep, was measured, and the declining rate of the estimated GFR was followed over 1 year. The severity of nocturnal hypoxemia was categorized as none (oxygen desaturation index2. Eighty patients (49.7%) were diagnosed with nocturnal hypoxemia; 64 patients were diagnosed with mild nocturnal hypoxemia, and 16 patients were diagnosed with moderate-to-severe nocturnal hypoxemia. The estimated GFR declined three- to fourfold faster in patients with moderate-to-severe nocturnal hypoxemia than patients with no or mild nocturnal hypoxemia (the mean values [95% confidence intervals] were −2.14 [−1.06 to −3.21], −3.02 [−1.31 to −4.74], and −8.59 [−2.00 to −15.2] ml/min per 1.73 m2 per year in the no, mild, and moderate-to-severe nocturnal hypoxemia groups, respectively; P=0.003). Nocturnal hypoxemia remained a significant predictor of decline in estimated GFR after adjustment for various baseline clinical factors. Conclusions: In nonobese patients with CKD, nocturnal hypoxemia is an independent risk factor of a rapid decline in kidney function.


  • Open Access

    Hypomagnesemia in Type 2 Diabetic Nephropathy

    by Yusuke Sakaguchi, Tatsuya Shoji, Terumasa Hayashi, Akira Suzuki, Morihiro Shimizu, Kensuke Mitsumoto, Hiroaki Kawabata, Kakuya Niihata, Noriyuki Okada, Yoshitaka Isaka, et al.

    OBJECTIVE There is now growing evidence that magnesium (Mg) deficiency is implicated in type 2 diabetes and its complications. However, it has not been fully elucidated whether hypomagnesemia is a predictor of end-stage renal disease (ESRD) in type 2 diabetic nephropathy. RESEARCH DESIGN AND METHODS This retrospective cohort study included 455 chronic kidney disease (CKD) patients (144 with type 2 diabetic nephropathy and 311 with nondiabetic CKD) who were hospitalized at Osaka General Medical Center for a CKD educational program between April 2001 and December 2007. The primary outcome was progression to renal replacement therapy. Participants were categorized based on serum Mg level into Low-Mg (serum Mg level ≤1.8 mg/dL) and High-Mg (serum Mg level >1.8 mg/dL) groups with the previously published normal lower limit chosen as the cutoff point. RESULTS Of the subjects with type 2 diabetic nephropathy, 102 progressed to ESRD during follow-up (median, 23 months). A multivariate Cox proportional hazards model showed that after adjustment for various demographic factors and laboratory data, the Low-Mg group had a 2.12-fold higher risk of ESRD than the High-Mg group (95% CI 1.28–3.51; P = 0.004). In contrast, 135 of the nondiabetic CKD subjects progressed to ESRD during follow-up (median, 44 months). No significant difference in outcome was found between the Low- and High-Mg groups of this population (adjusted hazard ratio, 1.15; 95% CI 0.70–1.90; P = 0.57). CONCLUSIONS Hypomagnesemia is a novel predictor of ESRD in patients with type 2 diabetic nephropathy.


  • Quiz Page April 2012

    by Yusuke Sakaguchi, Tatsuya Shoji, Kohki Shimazu, Hiroaki Fushimi, Terumasa Hayashi, Yoshiharu Tsubakihara


  • Open Access

    High Prevalence of Obstructive Sleep Apnea and Its Association with Renal Function among Nondialysis Chronic Kidney Disease Patients in Japan

    by Yusuke Sakaguchi, Tatsuya Shoji, Hiroaki Kawabata, Kakuya Niihata, Akira Suzuki, Tetsuya Kaneko, Noriyuki Okada, Yoshitaka Isaka, Hiromi Rakugi, Yoshiharu Tsubakihara

    Summary: Background and objectives: Obstructive sleep apnea (OSA) affects one of five adults in the general population. Although a high prevalence of OSA has been reported among dialysis patients, the association between nondialysis chronic kidney disease (CKD) and OSA has not been fully investigated. This cross-sectional study aimed to investigate the prevalence of OSA among nondialysis CKD patients in Japan and the association between renal function and OSA. Design, setting, participants, & measurements: Consecutive nondialysis CKD patients hospitalized mainly for CKD educational program, regardless of their sleep complaints, were enrolled. The diagnosis of OSA and its severity were measured using a type 3 portable monitor. Results: Overall (n = 100, 68.0% male, median age 66.5 years, body mass index [BMI] 23.1 kg/m2, estimated GFR [eGFR] 28.5 ml/min per 1.73 m2), 65% were diagnosed as OSA: mild OSA (apnea-hypopnea index [AHI] 5.0 to 14.9) in 32%, moderate OSA (AHI 15.0 to 29.9) in 25%, and severe OSA (AHI ≥ 30.0) in 8%. Multivariate logistic regression analysis revealed that a 10-ml/min per 1.73 m2 decrease in eGFR was associated with a 42% increased odds of OSA after adjustment for age, BMI, and diabetes mellitus. Moreover, in a generalized linear model, eGFR was inversely correlated with AHI after adjustment for covariates. Conclusions: This study demonstrated a high prevalence of OSA among nondialysis CKD patients in Japan and that the increased risk of OSA was significantly associated with decreased GFR among these patients. Further investigations are warranted to determine OSA's direct influence on cardiovascular disease.


  • An autopsy-proven case of myeloperoxidase-antineutrophil cytoplasmic antibody-positive polyarteritis nodosa with acute renal failure and alveolar hemorrhage

    by Yusuke Sakaguchi, Takuya Uehata, Hiroaki Kawabata, Kakuya Niihata, Akihiro Shimomura, Akira Suzuki, Tetsuya Kaneko, Tatsuya Shoji, Kohki Shimazu, Hiroaki Fushimi, et al.

    An 80-year-old woman positive for myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) was admitted with a 3-month history of fever, general malaise, and weight loss, after unsuccessful treatment with antibiotics. Upon admission, her fever persisted, and there was concomitant deterioration of renal function without active urine sediments. Furthermore, she developed hemoptysis, and chest computed tomography (CT) scan revealed bilateral diffuse alveolar hemorrhage. Although a renal biopsy was not performed because of her dementia, we initially suspected microscopic polyangiitis (MPA) on the basis of her clinical course. Because of her poor general condition, she was administered a low dose of prednisolone. Although her fever subsided, she suffered from intractable alveolar hemorrhage and eventually died from respiratory failure. During the autopsy, fibrinoid necrosis was restricted to medium-sized arteries, including the arcuate arteries of the kidneys and the bronchial arteries, without necrotizing crescentic glomerulonephritis and alveolar capillaritis. Therefore, polyarteritis nodosa (PAN) was diagnosed. It is important to distinguish between MPA and PAN because they can lead to life-threatening complications, and their treatment strategies and prognosis are different. When a patient presents with MPO-ANCA, alveolar hemorrhage, and acute renal failure with little evidence of glomerulonephritis, a differential diagnosis of PAN should be made; however, it is difficult to do so without pathological findings. Therefore, pathological examination should be carried out whenever possible.


    • 1 January 2009
      • Vol. 51  (5) , 550-6

    [Autopsy case of PR3-ANCA-associated vasculitis complicated with rectus muscle hematoma].

    by Yusuke Sakaguchi, Kakuya Niihata, Keiko Yasuda, Akihiro Shimomura, Takuya Uehata, Kazunori Inoue, Tetsuya Kaneko, Tatsuya Shoji, Yoshiharu Tsubakihara, Noriyuki Okada

    A 80-year-old man was admitted to our hospital because of coughing, hemosputum and dyspnea. As a chest X-ray showed infiltrates of the right lung, he was diagnosed as bacterial pneumonia and treated with antibiotics. However, after a few days, he exhibited hemoptysis and developed severe dyspnea, while laboratory findings showed rapid elevation of the serum creatinine level (5.55 mg dL). Computed tomography (CT) revealed large areas of ground glass opacity in the right lung, hence the hemoptysis was considered to be due to alveolar hemorrhage. As he had been diagnosed as chronic renal failure a few years before this admission and we also noticed that interstitial pneumonia with a slightly elevated level of C-reactive protein had existed from that time, ANCA-associated vasculitis was suspected to be the underlying pathogenesis. Accordingly, he was started on methylprednisolone pulse therapy and temporary hemodialysis resulted in improvement of dyspnea and renal function. PR3-ANCA was 12.4 EU, so he was diagnosed as PR3-ANCA-associated vasculitis. After a few days, he suddenly complained of abdominal pain, developing hypotension and anemia. Abdominal CT showed an irregular low-density mass in the right muscle, so he was diagnosed as rectus muscle hematoma. Surgery was performed and a massive hematoma was found in the rectus muscle without any ruptures of macroscopic vessels in the abdomen. Bleeding could not be stopped followed by multiple organ failure and the patient died four days postoperatively. Rectus muscle hematoma is an uncommon cause of acute abdomen, and has been reported in about 100 cases in Japan. It occurs because of a tear in epigastric vessels and is usually managed conservatively with a good prognosis, although hemodynamically unstable cases require surgery. To the best of the authors' knowledge, this is the first case of rectus muscle hematoma complicated with ANCA-associated vasculitis.